To evaluate the prognostic value of FOXD2‐AS1, recurrent pterygium patients were separated into ‘high‐risk’ (n = 13) and ‘low‐risk’ (n = 9) groups according to the best cut‐off level of FOXD2‐AS1. This evidence concerns the gene FOXD2 and pterygium.